Skip to main content

Diez-Canseco Russell's Form 4/A amendment

Amended

Vital Farms, Inc. (VITL) · filed Sep 15, 2023

Accession no.
0001209191-23-049596
Filed
Sep 15, 2023
Trade date
Sep 7, 2023
Filing delay
8 days
Rule 10b5-1 plan
Checked
Original filed
Sep 11, 2023

This filing lists 2 non-derivative transactions and 1 derivative transaction. Open-market sales total $303.0K. It was filed 8 days after the trade.

This amendment replaces 0001209191-23-048933 (filed Sep 11, 2023).

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Diez-Canseco RussellCIK 0001818591Director, Officer (President and CEO)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Sep 7, 2023Common StockMOption exerciseAcquired+27,500$3.25+$89,375229,794Direct
Sep 7, 2023Common StockSSaleDisposed−26,720$11.34F3−$303,004.8213,074Direct

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Sep 7, 2023Common StockMOption exerciseDisposed−27,500$0.00$067,185Direct

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

F1

The exercise and subsequent sales were made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 8, 2023.

F2

The initial Form 4 filed on September 11, 2023, inadvertently omitted an additional 10,780 options that were exercised and held. This amendment lists the correct number of shares exercised and beneficially owned after each transaction.

F3

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $11.07 to $11.54 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Referenced by the price of 1 transaction in Table I.

F4

Fully vested.

Read the full filing on SEC EDGAR (opens in a new tab)